IMPORTANCE Certain features of the lamina cribrosa may be associated with increased risk of glaucoma progression.
P rimary open-angle glaucoma (POAG) is an optic neuropathy characterized by progressive structural changes, loss of retinal ganglion cells and their axons, and accompanying damage to the visual field (VF).
1,2 The pathophysiology of glaucoma is not well understood, but it is generally accepted that both vascular and mechanical factors play a role in the development and progression of glaucoma.
2,3
The lamina cribrosa (LC) of the optic nerve head is considered a principal site of retinal ganglion cell axonal injury in the pathophysiology of glaucoma. 4 Animal studies have shown that eyes with increased intraocular pressure (IOP) often have abnormalities of the LC, 5, 6 including posterior lamina displacement, lamina thinning and defects, and pore deformities. Several cross-sectional human studies have revealed regional differences in LC structure, suggesting a mechanism of localized damage in glaucoma pathogenesis. [7] [8] [9] [10] Tatham et al 8 reported
that the largest LC defect area topographically corresponded with the location of localized retinal nerve fiber layer (RNFL) defects in the majority of eyes. Certain LC structural features, such as thickness, defects, and depth, may be associated with glaucoma progression.
11-14
Although a thinner and deeper LC has been shown to be a general risk factor for RNFL thinning, it has been suggested that when focal LC features are present, especially in the inferior region of the LC, RNFL thinning mostly occurs in that susceptible region.
14 Lamina cribrosa changes may compress the axons passing through the laminar pores, resulting in blockade of the axonal flow and thereby leading to a faster rate of progression. 8, 12 Alternatively, vascular insufficiency in eyes with LC defects may increase their rate of progression.
14 A limited number of longitudinal reports have shown that focal LC defects are strongly associated with the risk of glaucomatous VF progression. 11, 15 Faridi et al 11 followedPOAGeyes
with VF testing and documented that progression is more common in eyes with, rather than without, LC defects. However, the spatial relationship between LC defects and the rate of RNFL progression, and the factors that are associated with a faster rate of RNFL progression in eyes with focal LC defects are not well understood. Elevated IOP, [16] [17] [18] [19] [20] [21] older age, 16, 17, 19 lower central corneal thickness (CCT), 16, 17, 19, 20 decreased ocular perfusion pressure, [19] [20] [21] [22] and disc hemorrhage, 21, 23, 24 have been identified as risk factors for the development and progression of glaucoma. 25, 26 Nevertheless, the importance of each risk factor may vary in eyes with or without LC defects. 3 The goals of the present study were to determine whether an association exists between focal LC defects and the future rate of progressive RNFL thinning and to explore factors associated with the rate of RNFL thinning.
Methods
This was a longitudinal, observational, and prospective cohort study designed in September 2017 using patients with POAG or with suspected glaucoma enrolled in the Diagnostic Innovations in Glaucoma Study (DIGS) who underwent swept-source optical coherence tomography (SS-OCT) (DRI-OCT; Topcon) and spectral-domain (SD)-OCT optic nerve head imaging (Heidelberg Engineering Inc) from April 2012 to May 2017. The DIGS is an ongoing prospective, longitudinal project at the Hamilton Glaucoma Center, University of California, San Diego, designed to evaluate structural changes and visual function in glaucoma. Details of the DIGS protocol have been described previously. 27 In brief, all participants underwent an annual comprehensive ophthalmologic examination, including best-corrected visual acuity, slitlamp biomicroscopy, IOP measurement with Goldmann applanation tonometry, dilated fundus examination, stereoscopic optic disc photography, ultrasonographic pachymetry, and CCT measurements in both eyes. Semiannual examination included IOP, SS-OCT and SD-OCT imaging, and standard automated perimetry (VF) testing. Participants with a history of intraocular surgery (except for uncomplicated cataract surgery or glaucoma surgery), retinal pathology, nonglaucomatous optic neuropathy, uveitis, ocular trauma, Parkinson disease, Alzheimer disease, or stroke were excluded. The Institutional Review Board at the University of California, San Diego, approved the protocol, and the method adheres both to the tenets of the Declaration of Helsinki for research involving human participants 28 and to the Health Insurance Portability and Accountability Act. Written informed consent was obtained from all participants. Eyes were classified as glaucomatous if they had repeatable (≥2 consecutive), reliable (fixation losses and falsenegatives <33%, and <15% false-positives) abnormal VF test results, as defined by glaucoma hemifield test results outside reference limits confirmed by qualitative review of the VFs or glaucomatous optic nerve damage (ie, the presence of focal thinning, notching, or localized or diffuse atrophy of the RNFL). Glaucoma suspects had elevated IOP (≥22 mm Hg) or suspicious-appearing optic discs without repeatable glaucomatous VF damage. Only those patients with at least 2 years of follow-up and a minimum of 3 SD-OCT scanning sessions were included. To reduce the influence of the glaucoma severity on the results, participants without focal LC defects were matched to those with defects by using VF mean deviation (MD) as a measure of the severity of the disease. The Spectralis SD-OCT (Spectralis HRA+OCT; Heidelberg Engineering Inc) was used for RNFL measurements (software version, 5.4.7.0).
SS-OCT Imaging
We used SS-OCT 29 to image the optic nerve head for assessment of focal LC defect. Images with poor quality (quality score <50) or poor visibility of the LC (<70% visibility of the anterior laminar surface within the Bruch membrane opening) were excluded from analysis.
30
Horizontal and enface SS-OCT images were reviewed by 2 independent observers (S.M. and P.I.C.M.) who were masked to the participant's clinical information, including rate of glaucoma progression before the LC defects. Discrepancies between the 2 observers were resolved by consensus. A focal LC defect was defined as a laminar hole or laminar disinsertions violating the normal U-or W-shaped contour of the anterior laminar surface. 8, 11, 12, 30 Focal LC defects had to be at least 100 μm in diameter and greater than 30 μm in depth and had to be present on at least 2 consecutive B-scans to avoid false-positives ( Figure 1 and Figure 2 ; eFigure1intheSupplement). 8, 11, 12, 30 
VF Progression
Visual field progression was identified based on the eventbased Glaucoma Progression Analysis criteria 31 of "likely progression." Likely progression was defined as at least 3 points that showed significant change compared with 2 baseline examinations on 3 consecutive tests on the last follow-up visit.
31

Statistical Analysis
Mixed-effects modeling was used to compare clinical and ocular factors among groups. Linear mixed-effects modeling with random intercepts and random slopes was used to estimate the rates of change of RNFL thinning or VF MD worsening to account for repeated measurements over time and correlations between the 2 eyes of an individual. 32 Multivariable models were also constructed using covariates previously identified in the literature (VF MD, mean IOP during follow-up, and CCT) and covariates identified in the present study in univariate analysis with P <.10. The κ coefficient for the graders' assessment of the presence or absence and the number of focal LC defects was calculated as a measure of the reliability of interobserver agreement.
33 All statistical analyses were performed using STATA, version 14 (StataCorp). A 2-sided P < .05 was considered statistically significant.
Results
Among the 151 eyes of 121 POAG patients initially enrolled, 17 eyes were excluded for the following reasons: poor-quality SS-OCT images (16 eyes of 9 patients), failing to reach consensus in determining the presence of an LC defect by the 2 observers (1 eye). Of the remaining 134 eyes, 51 eyes (43 patients) had an LC defect, and 83 eyes (68 patients) did not have an LC defect. In the 51 eyes with focal LC defects, the mean (SD) number of focal LC defects per eye was 1.4 (0.6) (range, 1-3). The LC defects were classified as laminar disinsertion in 58 defects (85%). None of the eyes that were initially without an LC defect subsequently developed an LC defect during followup. There was excellent interobserver agreement (κ = 0.81) in determining the presence of LC defects in these 134 eyes. Baseline demographics and ophthalmic characteristics of eyes with or without LC defects are summarized in Table 1 . The mean (95% CI) age at baseline for individuals with LC defects was 69.5 (65.4-73.6) years, and for those without LC defects it was 
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Lamina Cribrosa Defects and Progressive Retinal Nerve Fiber Layer Loss in Glaucoma 69.6 (67.2-72.0) years; 18 individuals (41%) with LC defects and 35 individuals (51%) without LC defects were men; 6 individuals (14%) with LC defects and 17 individuals (25%) without were African American. There were no significant differences between patients with or without LC defects with respect to baseline clinical and ocular characteristics, including age, sex, race/ethnicity, CCT, axial length, diagnosis, baseline IOP, mean IOP during follow-up, and presence of disc hemorrhage. The mean baseline VF MD and global RNFL were also similar in eyes with or without LC defects. The mean number of visits and duration of followup were not significantly different between eyes with LC defects and eyes without LC defects. Table 2 and eFigure 2 in the Supplement summarize rates of global and sectoral RNFL thinning and VF MD deterioration in eyes with or without LC defects in univariate analysis. Compared with eyes without LC defects, eyes with LC defects had a mean (95% CI) faster rate of RNFL thinning globally ( . Differences between eyes with or without LC defects in the rates of RNFL deterioration in other regions did not reach statistical significance. Although eyes with LC defects had a faster rate of VF MD deterioration than eyes without LC defects, the difference between the slopes was of borderline significance (difference, −0.24 [95% CI, −0.49 to 0.01] dB/y, P = .05). Table 3 presents factors associated with the rate of global RNFL thinning in univariate and multivariable mixed-effects models. The presence of an LC defect was still associated with faster RNFL thinning after adjusting for potential confounding factors in multivariable linear mixed-effects models (β 2 , −0.41 [95% CI, −0.71 to −0.12], P = .005).
In event-based Glaucoma Progression Analysis, eyes with focal LC defects progressed more frequently than eyes without focal LC defects (13 of 51 eyes [25%] vs 9 of 83 eyes [11%], P = .03) (eTable in the Supplement). Eyes with LC defects were 2.62 times more likely to show VF progression than eyes without LC defects Abbreviations: LC, lamina cribrosa; MD, mean deviation; RNFL, retinal nerve fiber layer; VF, visual field.
a More negative values correspond to faster progression over time.
b P values are for rates of progression that were significantly faster than zero based on mixed-effects model results. Among the 51 eyes with focal LC defects, 20 eyes had defects located in the inferotemporal sector, and 19 eyes had LC defects located in the supratemporal sector. The LC defects were detected in both inferotemporal and supratemporal sectors in 12 eyes (29%). In 39 eyes with an LC defect in only the supratemporal or inferotemporal region, the localized rate of RNFL thinning in the sector corresponding to the LC defect was significantly faster than that in the unaffected sector (−1.60 [95% CI, −2.1 to −1.0] vs −0.70 [95% CI, −1.32 to −0.07] μm/y; difference: −0.90 [95% CI, −1.68 to −0.12] μm/y; P = .02).
The univariate and multivariable analyses of the associations between the rate of global RNFL thinning and clinical and ocular characteristics in eyes with or without LC defects are presented in Table 4 . Thinner CCT was the only factor that was associated with the rate of RNFL loss in eyes with LC defects in both univariate (β 2 , −0.08 [95% CI, −0.15 to −0.01], P = .03) and multivariable analyses (β 2 , −0.09 [95% CI, −0.14 to −0.04], P = .001). No association was found between mean IOP during follow-up and the mean rate of RNFL thinning in eyes with LC defects (β 2 , −0.05 [95% CI, −0.17 to 0.06], P = .36). By contrast, in eyes without LC defects, a greater mean IOP during follow-up was the only factor that was significantly associated with the mean rate of RNFL loss in univariate (β 2 , −0.06 [95% CI, −0.09 to −0.02], P < .001) and multivariable (β 2 , −0.08 [95% CI, −0.12 to −0.04], P < .001) analyses.
Discussion
The results of the present study showed that eyes with LC defects had a faster rate than eyes without LC defects of RNFL thinning globally and also in the supratemporal, inferotemporal, and inferonasal regions. Moreover, there were faster rates of RNFL progression in the regions corresponding to the LC defect location. These findings suggest that assessment of LC focal defects adds information to the evaluation of the risk and rate of glaucoma progression.
The rate of disease progression varies considerably among glaucoma patients. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Leeetal 12 used SD-OCT to assess LC thickness and depth and reported that greater posterior LC displacement and thinner LCs are associated with a faster progression of RNFL thinning. Focal LC defects can be detected using SS-OCT and are associated with localized RNFL defects, disc hemorrhage, and microvascular dropout. 7-9,14,34 A recent study reported that in glaucomatous eyes with disc hemorrhage, the presence of LC defects increased the rate of VF progression, especially when the disc hemorrhage is at the site of the LC defect. 15 The longitudinal studies that showed progression of glaucoma in eyes with LC defects focused on VF changes. 11, 12, 15 The results of the present study suggested that eyes with LC defects had a faster rate of RNFL thinning that was topographically associated with the location of the LC defects. This finding supports previous reports that showed regional differences in the LC properties may make specific portions of the 
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optic nerve particularly susceptible to neural loss. 4, 7, 8 These differences in the LC properties may be one of the reasons that glaucoma is often associated with localized RNFL thinning and a faster sectoral rate of RNFL thinning. 8 Suh and associates 14 reported a topographic association between laminar defects and microvascular dropout detected by OCT angiography and postulated that loss of structural support of the laminar beams due to the focal LC defect may directly or indirectly influence local retinal microvasculature. 35 These regional microvascular changes might further increase the rate of glaucoma progression in these regions. Our results were also consistent with the findings of Park et al, 13 which demonstrated a correlation between the location of inferior focal LC defects and progressive RNFL loss in the inferior region.
Although the association between LC morphology and VF progression has been shown in a limited number of studies, 11, 12, 15 little is known about the risk factors associated with glaucoma progression when LC defects are detected. In the present study, among glaucomatous eyes without LC defect, those with a lower mean IOP had a slower rate of RNFL loss. However, despite lower IOP values compared with the eyes without LC defect, no correlation was found between mean IOP and RNFL deterioration in eyes with LC defects. Most of the patients were undergoing intensive glaucoma treatment, with a mean IOP of 13.4 mm Hg during follow-up. Although even small reductions in IOP can decrease the risk of VF loss in eyes with glaucoma, 36 a more pronounced IOP reduction may be required in those eyes with LC defects because such eyes have greater susceptibility to glaucoma progression. In the present study, CCT was a significant risk factor for faster RNFL loss in eyes with LC defects. Previous studies have documented a significant correlation between a thinner CCT and the development of VF damage in ocular hypertensives and between a thinner CCT and glaucoma in eyes with POAG. 16, 17, 19, 20 Although IOP readings of eyes with a thinner CCT are underestimated, another possibility could be that a thin cornea may reflect biomechanical properties of the optic nerve head that are susceptible to glaucoma. The relationships between CCT, corneal hysteresis, stiffness of the cornea, and stiffness of the LC and optic nerve damage have been reported. [37] [38] [39] Wells et al 39 found an association between corneal hysteresis and optic disc surface compliance; thus, floppy cornea would be associated with floppy LC and peripapillary connective tissue. The reduced capability of LC displacement and its dampening effect would increase the strain in the LC and lead to glaucomatous damage. In eyes with an LC defect, we postulate that the dampening IOP fluctuations may prevent further optic nerve damage.
Limitations
Several limitations of this study should be mentioned. One limitation is that focal LC defects were based on subjective observation, and even with SS-OCT it can be challenging to visualize the deep optic nerve head structures and to identify an LC defect. However, this limitation was addressed at least in part by having 2 graders determine the presence of LC defects, and by the excellent interobserver agreement in determining the presence of the LC defects (κ = 0.81). The definition of LC defect may also have contributed to the results. Defects were required to be at least 100 μm in diameter in the present study. The size criteria were chosen to minimize the risk of labeling normal LC pores as defects, (ie, minimizing the number of false-positive classifications), to increase interobserver agreement, and to allow for comparisons with previous reports. 7, 8, 11, 14, 40 . This suggests that LC defects could be much smaller than the criteria used in the present study. Even though we included 134 eyes with a mean follow-up of more than 3.5 years, a large proportion of our cases showed early glaucoma, and this follow-up period might not have been long enough to detect significant global VF deterioration in these participants because high intraindividual variability of VF test results necessitates a large number of visits. Finally, we did not exclude eyes with prior glaucoma surgery; such surgery can change the optic nerve head morphology, as anterior lamina depth and bowing have been shown to be affected by trabeculectomy. However, in the present study, the proportion of eyes with or without LC defects that had undergone glaucoma surgery was similar.
Conclusions
The present study showed that eyes with LC defects had faster rates of RNFL thinning than eyes without LC defects and that the thinning was more pronounced in the region of the LC defect. The risk factors for progression in eyes with LC defects were different from those in eyes without LC defects. It is not yet known whether aggressive treatment to reduce the likelihood of glaucomatous progression is beneficial in eyes with LC defects. The lamina cribrosa (LC) has long been considered the primary site of glaucoma damage. The use of optical coherence tomography to visualize the LC has enabled in vivo examination of this tissue in humans. Instead of simply views of the surface of the LC and LC irregularities or measurements of LC thickness, we can now visualize the 3-dimensional (3-D) structure of the LC, its defects, and its microstructure. While defects and LC thickness can be seen on optical coherence tomography B-scan cross sections (if the cross section happens to pass through the region of interest), they are best noted in 3-D volumetric imaging of the LC.
In this issue of JAMA Ophthalmology, a longitudinal study by Moghimi et al 1 underscores the potential power of using LC defects to enable more precise estimation of glaucoma progression. A central challenge of treating patients with glaucoma is detecting progression in a manner that is timely, sensitive, and specific enough to prompt judicious escalation in treatment. To that end, this study and other studies suggest that, when detected, LC defects may provide valuable information that can inform treatment. In particular, Moghimi et al 1 found that defects in the LC were an independent risk factor for thinning of the retinal nerve fiber layer (RNFL) and that the location of the LC defects generally corresponded spatially to areas of subsequent RNFL thinning. Several methodologic limitations of the study by Moghimi et al 1 warrant discussion. Most notably, the approaches to image acquisition and assessment were suboptimal for detecting LC abnormalities. The investigators defined LC defects based on depth and diameter criteria in consecutive B-scans from swept-source optical coherence tomography images. For thorough evaluation of the LC, such 2-D images are insufficient. Although 2-D data may provide evidence of gross tissue abnormalities, 3-D imaging enables more nuanced assessment of the LC microstructure. Current technology has the potential to provide a more precise, sensitive, automated, and 3-D approach to identifying and analyzing LC defects. By leveraging current technology, the investigators could have identified smaller LC defects, analyzed LC defects in greater detail, and considered additional features of interest, including the pores through which retinal ganglion cell axons traverse the LC, 2 the changes in the location and morphology of the central retinal vessel trunk, 3 and the thickness of LC beams.
4
Reliance on expert classification of defects rather than on automated methods of LC assessment may have further hindered the detection of LC abnormalities. The study design attempted to safeguard against bias and human error through the use of 2 readers and a protocol for reaching consensus. Still, it is possible that bias and human error influenced LC defect detection, especially because the LC defect was solely defined based on 2-D instead of 3-D assessments. As the authors point out, the predefined criteria for marking an LC defect (≥100-μm diameter and >30-μm depth) may have led to the identification of only very large abnormalities. These criteria likely failed to capture early laminar defects. Although the authors maximized the specificity of defect detection with this approach, there was likely a substantial sacrifice in sensitivity. Failure to identify early and small LC defects may have significantly impacted the resultant associations between detected LC abnormalities and glaucomatous RNFL progression.
More accurate and detailed data on LC microstructural abnormalities could have enabled stronger or different associations with glaucomatous RNFL progression. For instance, given the limitations of the study by Moghimi et al, 1 it is uncertain whether LC defects are topographically associated with subsequent RNFL thinning for only large LC defects or if analysis of subtler defects would have revealed a similar association. In addition, the authors noted that none of the eyes without an initial LC defect developed one subsequently in the study period. Several of the eyes in that group progressed, making it unclear whether LC defects were not necessary for glaucomatous progression (and not ubiquitous in eyes that progress) or, alternatively, whether LC defects indeed developed in these eyes during the study period but were not large enough for detection by the chosen method of image assessment. In addition to analyzing the association between LC defects and RNFL thinning, the study by Moghimi et al 1 sought
to delineate which characteristics of eyes with or without LC defects were associated with a faster rate of thinning. In eyes with LC defects, this analysis revealed an association between low central corneal thickness and a faster rate of RNFL thinning. In eyes without LC defects, there was an association between high mean intraocular pressure (IOP) and a faster rate of RNFL thinning. Although these results are interesting, inclusion of additional factors that may be associated with progression could have enriched the findings. For instance, the investigators considered the association between rate of RNFL thinning and mean IOP but neglected to address change in IOP from baseline. Given the variability in both baseline IOP and goal IOP among patients with glaucoma, change in IOP may 
